A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosus
Clinical trial NCT05123586 · TERMINATED
Trial details
- NCT number
- NCT05123586
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-07
- Primary completion
- 2023-12-29
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.